Search General Info
Search Education
Search Partnering Companies
MicuRx Pharmaceuticals
3:30 PM - 3:45 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104B
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
MicuRx was founded by Dr. Zhengyu Yuan and Dr. Mikhail F. Gordeev, and is led by an experienced, international scientific and management teams. MicuRx has established R&D centers in China and the US, which has capabilities of basic research, drug development, clinical development and registration. We commercialize our own products in China. Historically MicuRx focused on anti-infectives and are now expanding to other therapy areas.
MicuRx has built a robust pipeline of 4 independently developed innovative drug candidates, focusing on new antibiotics against multidrug-resistant “super-bacteria”. Our goal is to license those to a partner for ex-China regions.
MicuRx is also wishes to in-license late-stage or approved medicines for commercialization in China and are considering several different therapy areas.
Please contact us for more information.
MicuRx has built a robust pipeline of 4 independently developed innovative drug candidates, focusing on new antibiotics against multidrug-resistant “super-bacteria”. Our goal is to license those to a partner for ex-China regions.
MicuRx is also wishes to in-license late-stage or approved medicines for commercialization in China and are considering several different therapy areas.
Please contact us for more information.
![](https://778c1607566f28c5e8fd-e6db6de54823ad7fd298e0f6ff75b72a.ssl.cf1.rackcdn.com/BIO_4121_EOISBJNL_547_MicuRxPharmaceuticals-FileId-330094.jpg)
Ticker:
688373
Exchange:
Shanghai Star Exchange
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2007
Main Therapeutic Focus:
Infectious Diseases
Lead Product in Development:
contezolid
Development Phase of Primary Product:
Phase III
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
![](https://www.conferenceharvester.com/uploads/harvester/photos/EOISBJNL-Presenter-LiJ.jpg)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved